---
layout: post
title: "港股成交额TOP20：药明生物大涨超10% “吃药”行情又起风！"
date: 2022-02-15 16:32:15 +0800
categories: emnews
tags: 东财滚动新闻
---
> “吃药”行情又起风！药明生物大涨超10%，成交额35.76亿港元；腾讯跌0.42%，成交额65.28亿港元；美团跌2.55%，成交额32.62亿港元。

<p>2月15日港股成交额TOP20榜单如下，<strong><span id="Info.116.00700"><a href="http://quote.eastmoney.com/unify/r/116.00700" class="keytip" data-code="116,00700">腾讯控股</a></span>跌0.42%，成交额65.28亿港元，居排行榜首；<span id="Info.116.02269"><a href="http://quote.eastmoney.com/unify/r/116.02269" class="keytip" data-code="116,02269">药明生物</a></span>大涨超10%，成交额35.76亿港元，为今日成交额榜单亚军；<span id="Info.116.03690"><a href="http://quote.eastmoney.com/unify/r/116.03690" class="keytip" data-code="116,03690">美团-W</a></span>跌2.55%，成交额32.62亿港元，位居第三。</strong></p><p>昨日(2月14日)，<span id="stock_1.601555"><a href="http://quote.eastmoney.com/unify/r/1.601555" class="keytip" data-code="1,601555">东吴证券</a></span><span id="quote_1.601555"></span>发布<span id="Info.314"><a href="http://data.eastmoney.com/report/" class="infokey">研究报告</a></span>，旗帜鲜明地指出，<strong>CXO龙头PEG已回归至1左右，板块处于估值底部。</strong>对于<span web="1" href="http://quote.eastmoney.com/unify/r/116.02269" class="em_stock_key_common" data-code="116,02269">药明生物</span>被列入UVL一事，该机构也持乐观态度，认为<strong>对公司及行业影响极为有限，且有望未来数月内移出清单。</strong></p><p>基于医药投资的变与不变，<strong><span id="Info.116.06178"><a href="http://quote.eastmoney.com/unify/r/116.06178" class="keytip" data-code="116,06178">光大证券</a></span>认为未来应当积极把握创新化和国际化方向的投资机会</strong>。创新药与疫苗方面，推荐<strong><span id="Info.116.01801"><a href="http://quote.eastmoney.com/unify/r/116.01801" class="keytip" data-code="116,01801">信达生物</a></span>(H)、荣昌生物(H)</strong>；CXO方面，推荐<strong><span web="1" href="http://quote.eastmoney.com/unify/r/116.02269" class="em_stock_key_common" data-code="116,02269">药明生物</span></strong><strong>(H)、<span id="Info.116.03759"><a href="http://quote.eastmoney.com/unify/r/116.03759" class="keytip" data-code="116,03759">康龙化成</a></span>、<span id="stock_1.688131"><a href="http://quote.eastmoney.com/unify/r/1.688131" class="keytip" data-code="1,688131">皓元医药</a></span><span id="quote_1.688131"></span>、<span id="stock_0.300725"><a href="http://quote.eastmoney.com/unify/r/0.300725" class="keytip" data-code="0,300725">药石科技</a></span><span id="quote_0.300725"></span></strong>；器械设备与生命科学领域，推荐<strong><span id="stock_0.300760"><a href="http://quote.eastmoney.com/unify/r/0.300760" class="keytip" data-code="0,300760">迈瑞医疗</a></span><span id="quote_0.300760"></span>、<span id="Info.116.00853"><a href="http://quote.eastmoney.com/unify/r/116.00853" class="keytip" data-code="116,00853">微创医疗</a></span>(H)、<span id="stock_1.600587"><a href="http://quote.eastmoney.com/unify/r/1.600587" class="keytip" data-code="1,600587">新华医疗</a></span><span id="quote_1.600587"></span>、<span id="stock_0.300685"><a href="http://quote.eastmoney.com/unify/r/0.300685" class="keytip" data-code="0,300685">艾德生物</a></span><span id="quote_0.300685"></span>、<span id="stock_1.688301"><a href="http://quote.eastmoney.com/unify/r/1.688301" class="keytip" data-code="1,688301">奕瑞科技</a></span><span id="quote_1.688301"></span></strong>；创新前沿技术方面，关注<strong>艾博生物</strong>等未上市企业；内需消费方面，推荐<strong><span id="Info.116.01951"><a href="http://quote.eastmoney.com/unify/r/116.01951" class="keytip" data-code="116,01951">锦欣生殖</a></span>(H)、<span id="stock_1.603883"><a href="http://quote.eastmoney.com/unify/r/1.603883" class="keytip" data-code="1,603883">老百姓</a></span><span id="quote_1.603883"></span>、<span id="stock_0.000915"><a href="http://quote.eastmoney.com/unify/r/0.000915" class="keytip" data-code="0,000915">华特达因</a></span><span id="quote_0.000915"></span>、<span id="stock_0.300294"><a href="http://quote.eastmoney.com/unify/r/0.300294" class="keytip" data-code="0,300294">博雅生物</a></span><span id="quote_0.300294"></span></strong>。</p><center><img src="https://dfscdn.dfcfw.com/download/D25201415792244037581_w876h1768.jpg" emheight="1171" orginial_src="https://dfscdn.dfcfw.com/download/D25201415792244037581_w876h1768_o.jpg" style="border:#d1d1d1 1px solid;padding:3px;margin:5px 0;" width="580" /></center><p><strong>相关阅读：</strong></p><p><a href="https://finance.eastmoney.com/a/202202152277167395.html"><strong>葛兰基金大涨！CXO成反弹先锋机构称板块估值底已现</strong></a></p><p><a href="https://stock.eastmoney.com/a/202202152276885729.html"><strong>八大券商主题策略：“吃药”行情又起风！CXO、中药、医疗器械等细分龙头梳理</strong></a><br /></p><p class="em_media">（文章来源：哈富资讯）</p>

<http://hk.eastmoney.com/news/11382,202202152277250149.html>

[返回东财滚动新闻](//finews.withounder.com/emnews/)｜[返回首页](//finews.withounder.com/)